Overview

Safety Trial of IRESSA, Cisplatin and Radiation Therapy for Patients With Head and Neck Cancer

Status:
Terminated

Trial end date:
2006-09-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to find out whether adding ZD1839 to standard treatment (Cisplatin and Radiation Therapy) of unresectable head and neck cancers is better than cisplatin and radiation alone.

Phase:

Phase 1/Phase 2

Details

Lead Sponsor:

Weill Medical College of Cornell University

Treatments:

Cisplatin
Gefitinib